Abstract
INTRODUCTION: Nanomedicine provides a promising platform for manipulating dendritic cells (DCs) and the ensuing adaptive immune response. For the induction of regulatory responses, DCs can be targeted in vivo with nanoparticles incorporating tolerogenic adjuvants and auto-antigens or allergens.
METHODS: Here, we investigated the tolerogenic effect of different liposome formulations loaded with vitamin D3 (VD3). We extensively phenotyped monocyte-derived DCs (moDCs) and skin DCs and assessed DC-induced regulatory CD4+ T cells in coculture.
RESULTS: Liposomal VD3 primed-moDCs induced the development of regulatory CD4+ T cells (Tregs) that inhibited bystander memory T cell proliferation. Induced Tregs were of the FoxP3+ CD127low phenotype, also expressing TIGIT. Additionally, liposome-VD3 primed moDCs inhibited the development of T helper 1 (Th1) and T helper 17 (Th17) cells. Skin injection of VD3 liposomes selectively stimulated the migration of CD14+ skin DCs.
DISCUSSION: These results suggest that nanoparticulate VD3 is a tolerogenic tool for DC-mediated induction of regulatory T cell responses.
Original language | English |
---|---|
Article number | 1137538 |
Number of pages | 16 |
Journal | Frontiers in Immunology |
Volume | 14 |
DOIs | |
Publication status | Published - 2023 |
Externally published | Yes |
Bibliographical note
Funding Information:This work was supported by Health Holland and “Samenwerkende Gezondheidsfonden” (SGF), with the LSH-TKI project the LSH-TKI project DC4Balance LSHM18056-SGF. The sponsors had no role in the study design, collection, analysis, interpretation of data, report writing, or decision to submit the manuscript for publication. Acknowledgments
Publisher Copyright:
Copyright © 2023 Nagy, Lozano Vigario, Sparrius, van Capel, van Ree, Tas, de Vries, Geijtenbeek, Slütter, de Jong and for the DC4Balance consortium.
Keywords
- T regulatory cells (Tregs)
- allergies
- autoimmunity
- dendritic cells
- immunotherapy
- liposome
- tolerance
- vitamin D3